This track focuses on the latest findings in neonatal diabetes, including genetic and environmental factors influencing its onset. Researchers will present innovative approaches to diagnosis and management in this vulnerable population.

This session will explore the autoimmune processes underlying Type 1 diabetes and related disorders. Discussions will include the role of immune interventions and potential therapeutic strategies.

This track will address the challenges and management strategies associated with gestational diabetes. Experts will discuss its long-term implications for both mothers and children.

Focusing on rare forms of diabetes, this session will delve into monogenic diabetes and idiopathic cases. Presentations will highlight diagnostic challenges and personalized treatment options.

This track will examine the unique aspects of diabetes management in children and adolescents. Topics will include early diagnosis, treatment strategies, and psychosocial considerations.

This session will cover the various complications associated with diabetes, including cardiovascular, renal, and neurological issues. Researchers will present findings on prevention and management strategies.

This track will showcase cutting-edge technologies for diabetes management, including continuous glucose monitoring and insulin delivery systems. Discussions will focus on their impact on patient outcomes.

This session will highlight the role of computational methods in understanding diabetes pathophysiology and treatment. Presentations will include data analytics, modeling, and simulation studies.

This track will feature case discussions that emphasize patient-oriented approaches in endocrinology. Experts will share insights on individualized care plans for diabetes patients.

This session will focus on the discovery of new biomarkers and therapeutic agents for diabetes treatment. Researchers will discuss the implications of these advancements for clinical practice.

This track will address the regulatory challenges and economic considerations in diabetes research and treatment. Discussions will include funding, policy implications, and market access.